Use the tabs below to explore our range of posters, ePosters and resources from AACR 2020. Or find previous years posters at www.charlesriveroncology.com. Patients are waiting. We'll keep moving at the speed of oncology.
Our scientists, in collaboration with our partners, proudly presented 19 scientific posters at AACR 2020. You can download poster presentations below covering a variety of research topics, or click on the ePoster Presentations tab to watch the poster videos.
Antibody Technologies
|
Advanced Engineering Using CAR-T Display Libraries: Ultra-High Throughput Functional Screen |
Experimental and Molecular Therapeutics
|
Co-administration of iRGD and therapeutic EGFR-antibodies Cetuximab and Panitumumab enhances drug penetration in NSCLC PDX based 3D multicellular spheroids |
Immunology
Tumor Biology
Featured ePoster
An Integrated In Vitro and In Vivo Approach Providing Insights in Immune Modulation
Presented by Shilina Roman, Associate Director Integrated Biology
Featured ePoster
In Vitro Cell Based Cytotoxicity and T Cell Activation Assays to Assess Safety and Efficacy of Engineered T Cell Therapies
Presented by Sanne Holt, Group Leader, Biology
Featured ePoster
Longitudinal Characterization of Patient-Derived Orthotopic Xenograft Brain Tumor Models
Presented by Tuulia Huhtala, Head of Biomarkers
A translational immuno-oncology platform to model T cell activation and Tex recovery in the tumor microenvironment
In vitro tumor killing assays for predicting cellular therapeutic efficacy
A mouse orthotopic model of pancreatic cancer and response to treatment
Evaluation of in vivo anti-tumor response of solid tumors in a novel immune cell-humanized NOD-Prkdcem26Cd52Il2rgem26Cd22/NjuCrl mouse model
A Panel of NSCLC patient derived xenografts displays a distinct sensitivity profile towards checkpoint
PDX models driven by EGFR Optimizing the preclinical profiling of EGFR targeting agents
The single mouse trial format predicts the sensitivity towards checkpoint
Enhanced anti-tumor lymphocyte function and frequencies measured by multichromatic flow
In the research community, we know our work doesn’t stop when crisis hits. Keep yours going strong with this collection of insights, tools, and resources prepared by our team. Or, take a deep dive into our comprehensive portfolio of oncology research models, tools, and services at www.charlesriveroncology.com.
On-Demand Webinars
A New Translational In Vivo Tool for Oncology Drug Discovery: Zebrafish Tumor Xenograft Model
Presented by: Julia Schüler, DVM, PhD, Research Director, Charles River
Anna Erkstam, PhD, Chief Operating Officer (COO), BioReperia AB
Lasse Jensen, PhD, Chief Technical Officer (CTO) and Co-Founder, BioReperia AB
Catching Patient Diversity In Vitro: PDX-based Assays in Oncology Drug Discovery
Claudia Göttlich, PhD, Study Director, In Vitro, Charles River
When Immune Cells Invade a Tumor: Using the TME to Drive Your Oncology Research
Presented by: Robert Nunan, PhD, Group Leader, Charles River
Emergent Humanized Mouse Models Are Driving Immuno-Oncology Strategy
Presented by: Paula Milinani de Marval, PhD, Associate Research Director, Discovery Services, Charles River
Microdialysis: A Novel Tool to Sample the Tumor Microenvironment
Presented by: Nadege Morisot, PhD, Senior Scientist, In Vivo Pharmacology Charles River
Preclinical Imaging: A Translational Approach to Assess New Cancer Treatments
Presented by: Tuulia Huhtala, PhD, Head of Biomarkers and Molecular Imaging, Charles River
How to Design & Execute Successful CAR-T Cell Therapy Programs (Available in The Source℠)
Presented by: David Harris, PhD, Research Director, Oncology, Charles River
Bioinformatics: Mining Big Data to Discover Precision Oncology Therapies
Presented by: Max Bylesjo, PhD, MSc, Technical Director, Fios Genomics
Tools
Blogs
Eureka Blog
Cancer Doesn't Stop For a Pandemic
Eureka Blog
Humanized Mice for Immuno-Oncology
Podcast
Sounds of Science
Episode 20: A Tumor's Lair